Philippe Lopes-Fernandes
Corporate Officer/Principal chez IPSEN
Postes actifs de Philippe Lopes-Fernandes
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IPSEN | Corporate Officer/Principal | 01/10/2020 | - |
Histide AG
 Histide AG Internet Software/ServicesTechnology Services Histide AG operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents. The company was founded by Omar F. Zouani , Benoît Lienard and Veronika Gocheva in 2014 and is headquartered in Schindellegi, Switzerland. | Directeur/Membre du Conseil | - | - |
Bakx Therapeutics, Inc.
 Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020. | Directeur/Membre du Conseil | - | - |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Consultant / Advisor | - | - |
Historique de carrière de Philippe Lopes-Fernandes
Anciens postes connus de Philippe Lopes-Fernandes
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | - | - |
Formation de Philippe Lopes-Fernandes
| Institut Supérieur de Gestion | Undergraduate Degree |
Statistiques
Internationale
| France | 3 |
| Etats-Unis | 3 |
| Suisse | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Technology Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IPSEN | Health Technology |
| MERCK KGAA | Health Technology |
| Entreprise privées | 3 |
|---|---|
Histide AG
Histide AG Internet Software/ServicesTechnology Services Histide AG operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents. The company was founded by Omar F. Zouani , Benoît Lienard and Veronika Gocheva in 2014 and is headquartered in Schindellegi, Switzerland. | Technology Services |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020. | Health Technology |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Finance |
- Bourse
- Insiders
- Philippe Lopes-Fernandes
- Expérience
